16.89 (-%)
As of Nov 01, 2024
Source:
Assembly Biosciences, Inc is a biopharmaceutical company advancing clinical candidates with the potential to improve the lives of millions of people living with chronic hepatitis B virus (HBV) infection around the world, an early-stage development program targeting high-recurrence genital herpes and research programs focused on the discovery of novel antivirals to treat devastating viral diseases, including hepatitis delta virus (HDV), herpes simplex virus type 2 (HSV-2) and transplant-related herpesviruses.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (833) 409-4583 |
Industry | manufacturing |
CEO | Jason A. Okazaki. |
Website | www.assemblybio.com |